# HotSpot Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hotspot-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.hotspotthera.com
- Total disclosed funding: $210M
- Latest round: Series C (Jun 1, 2020)
- Investors on record: 14

## About

Founded in 2017 and based in Massachusetts, US, HotSpot Therapeutics, Inc. provides a platform Smart Allostery for the research and development of allosteric therapeutics. In November 2021, the firm raised USD 100 million in Series C funding led by investor Pivotal Life Sciences, with participation from  investors B Capital Group, CaaS Capital Management, Life Sciences Partners, Monashee Investment Management, Pavilion Capital Partners, and Revelation Partners. Returning investors Atlas Venture, MRL Ventures Fund, Sofinnova Partners, SR One, and Tekla Capital Management also participated in the round.

## Funding rounds

- Series C, Jun 1, 2020, $100M — Atlas Venture, Sofinnova Partners, EQT Life Sciences, Tekla Capital Management, Monashee Investment Management, Revelation Partners, B Capital, Pivotal Life Sciences, MRL Ventures Fund, Pavilion Capital Partners, CaaS Capital Management
- Series B, May 21, 2020, $65M — Atlas Venture, Sofinnova Partners, SR One, Tekla Capital Management, Brace Pharma Capital, MRL Ventures Fund, Solasta Ventures
- Series A, Jul 17, 2018, $45M — Atlas Venture, Sofinnova Partners
- Seed, Mar 1, 2017 — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Seed, Series A, Series B, Series C
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B, Series C
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series B, Series C
- Brace Pharma Capital (https://capitalatlas.ai/funds/brace-pharma-capital) — Series B
- MRL Ventures Fund (https://capitalatlas.ai/funds/mrl-ventures-fund) — Series B, Series C
- Solasta Ventures (https://capitalatlas.ai/funds/solasta-ventures) — Series B
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series C
- Monashee Investment Management — Series C
- Revelation Partners (https://capitalatlas.ai/funds/revelation-partners) — Series C
- B Capital (https://capitalatlas.ai/funds/b-capital) — Series C
- Pivotal Life Sciences (https://capitalatlas.ai/funds/pivotal-life-sciences) — Series C
- Pavilion Capital Partners (https://capitalatlas.ai/funds/pavilion-capital-partners) — Series C
- CaaS Capital Management (https://capitalatlas.ai/funds/caas-capital-management) — Series C